Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 11 , Pages 2159-2163 , November 2007

Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients

  • Minoru Miyake, DDS, PhD

      Affiliations

    • Associate Professor, Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Miyake: Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan
    • ,
  • Yumiko Ohbayashi, DDS, PhD

      Affiliations

    • Assistant Professor, Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
    • ,
  • Akinori Iwasaki, DDS, PhD

      Affiliations

    • Assistant Professor, Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
    • ,
  • Takaaki Ogawa, DDS, PhD

      Affiliations

    • Assistant Professor, Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
    • ,
  • Shunichiro Nagahata, DDS, PhD

      Affiliations

    • Professor and Chair, Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.

References 

  1. Washio M, Mizoue T, Kajioka T, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital. Public Health. 1997;111:187
  2. Mehtar S. The continuing problem of “hospital staphylococci”: Why?. J Chemother. 1994;6(Suppl 4):25
  3. Abe M, Takaichi F, Amano H, et al. Antimicrobial susceptibility and beta-lactamase producibility of bacteria clinically isolated during the period from December 1999 to February 2000. Jpn J Antibiot. 2002;55(Suppl A):54;[in Japanese]
  4. Gould IM. The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2005;61:277
  5. O’Kane GM, Gottlieb T, Bradbury R. Staphylococcal bacteraemia: The hospital or the home? (A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993). Aust N Z J Med. 1998;28:23
  6. Rao GG. Risk factors for the spread of antibiotic-resistant bacteria. Drugs. 1998;55:323
  7. Takeuchi K, Tsuzuki Y, Ando T, et al. Clinical studies of enteritis caused by methicillin-resistant Staphylococcus aureus. Eur J Surg. 2001;167:293
  8. Nikodemski T. Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit. Ann Acad Med Stetin. 1999;45:211;[in Polish]
  9. Matsuoka K, Nagatomi Y, Imanishi K, et al. A study on MRSA infections and replacement of bacteria: Efficacy of vancomycin-ceftazidime combination therapy. Jpn J Antibiot. 1994;47:1363;[in Japanese]
  10. Mayall B, Martin R, Keenan AM, et al. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward. J Hosp Infect. 1996;32:257
  11. Takeda S, Kono K, Arakawa K. Relation between candidiasis and nutrition of patients and MRSA infection. Kansenshogaku Zasshi. 1997;71:899;[in Japanese]
  12. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005;33:3
  13. Muller A, Talon D, Potier A, et al. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Crit Care. 2005;9:R246
  14. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871
  15. Hitomi S, Kubota M, Mori N, et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect. 2000;46:123
  16. Kikuchi K. Mupirocin-resistant MRSA in Japan. Nippon Rinsho. 2001;59:724;[in Japanese]
  17. Walker ES, Vasquez JE, Dula R, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: Does mupirocin remain effective?. Infect Control Hosp Epidemiol. 2003;24:342

PII: S0278-2391(07)01532-7

doi: 10.1016/j.joms.2007.04.026

Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 11 , Pages 2159-2163 , November 2007

Article Tools

* Image Usage & Resolution